RAGE ligands induce apoptotic cell death of pancreatic β-cells via oxidative stress

International Journal of Molecular Medicine

Volumn 26, Issue 6, 2010, Pages 813-818

  Lee, Byung Wan ^a,b   Chae, Hee Young ^a   Kwon, Soo Jin ^a   Park, So Youn ^a   Ihm, Jahei ^c   Ihm, Sung Hee ^a  

^a Hallym University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Kyonggi University   (South Korea)

Author keywords

Apoptosis; Diabetes; Pancreatic cells; Receptor for AGE ligands

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIOXIDANT; HIGH MOBILITY GROUP B1 PROTEIN; MESSENGER RNA; OXIDOREDUCTASE INHIBITOR; PROTEIN; PROTEIN S100B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL ISOLATION; CELL LOSS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR MEMBRANE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; HMGB1 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIGANDS; MALE; NERVE GROWTH FACTORS; OXIDATIVE STRESS; RATS; RATS, INBRED OLETF; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS; SWINE;

EID: 78649965893     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm-00000529     Document Type: Article

References (30)

1. Huebschmann AG, Regensteiner JG, Vlassara H and Reusch JE: Diabetes and advanced glycoxidation end products. Diabetes Care 29: 1420-1432, 2006.
2. Neeper M, Schmidt AM, Brett J, et al: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992.
3. Yan SF, Ramasamy R and Schmidt AM: Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4: 285-293, 2008.
4. Hofmann MA, Drury S, Fu C, et al: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. Cell 97: 889-901, 1999.
5. Dumitriu IE, Baruah P, Valentinis B, et al: Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 174: 7506-7515, 2005.
6. Tanji N, Markowitz GS, Fu C, et al: The expression of advanced glycation endproducts and their cellular receptor RAGE in diabetic nephropathy and non-diabetic renal disease. J Am Soc Nephrol 11: 1656-1666, 2000.
7. Toth C, Rong LL, Yang C, et al: Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes 57: 1002-1017, 2008.
8. Wautier MP, Chappey O, Corda S, Stern DM, Schmidt AM and Wautier JL: Activation of NADPH oxidase by advanced glycation endproducts (AGEs) links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280: E685-E694, 2001.
9. - generation by mononuclear phagocytes in diabetes. J Leukoc Biol 1: 520-527, 2007.
10. Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C and Feldman EL: Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148: 548-558, 2007.
11. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF and Schmidt AM: Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15: R16-R28, 2005.
12. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA and Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110, 2003.
13. Marchetti P, Del Guerra S, Marselli L, et al: Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin. J Clin Endocrinol Metab 89: 5535-5541, 2004.
14. Robertson RP and Harmon JS: Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41: 177-184, 2006.
15. Kajimoto Y and Kaneto H: Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci 1011: 168-176, 2004.
16. Chen Y, Yan SS, Colgan J, Zhang HP, Luban J, Schmidt AM, Stern D and Herold KC: Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 173: 1399-1405, 2004.
17. Shanmugam N, Todorov IT, Nair I, Omori K, Reddy MA and Natarajan R: Increased expression of cyclooxygenase-2 in human pancreatic islets treated with high glucose or ligands of the advanced glycation endproduct-specific receptor (AGER), and in islets from diabetic mice. Diabetologia 49: 100-107, 2006.
18. Kim JH, Kim HI, Lee KW, et al: Influence of strain and age differences on the yields of porcine islet isolation: extremely high islet yields from SPF CMS miniature pigs. Xenotransplantation 14: 60-66, 2007.
19. Ihm SH, Matsumoto I, Sawada T, et al: Donor age on function of isolated human islets. Diabetes 55: 1361-1368, 2006.
20. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M and Makino H: Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 54: 97-104, 2006.
21. Chen M, Yang Z, Wu R and Nadler JL: Lisofylline, a novel antiinflammatory agent, protects pancreatic beta-cells from proinflammatory cytokine damage by promoting mitochondrial metabolism. Endocrinology 143: 2341-2348, 2001.
22. Castedo M, Ferri K, Roumier T, Metiyier D, Zamzami N and Kroemer G: Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Methods 265: 39-47, 2002.
23. Higashi T, Sano H, Saishoji T, et al: The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 46: 463-472, 1997.
24. Shaw SS, Schmidt AM, Banes AK, Wang X, Stern DM and Marrero MB: S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes 52: 2381-2388, 2003. (Pubitemid 37059510)
25. Reddy MA, Li SL, Sahar S, Kim YS, Xu ZG, Lanting L and Natarajan R: Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. J Biol Chem 281: 13685-13693, 2006.
26. Kislinger T, Tanji N, Wendt T, et al: RAGE mediates inflammation and enhanced expression of tissue factor in the vasculature of diabetic apolipoprotein E null mice. Arterioscler Thromb Vasc Biol 21: 905-910, 2001.
27. Wendt TM, Tanji N, Guo J, et al: RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162: 1123-1137, 2003.
28. Yamagishi S, Amano S, Inagaki Y, et al: Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes. Biochem Biophys Res Commun 290: 973-978, 2002.
29. Kaji Y, Amano YS, Usui T, et al: Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 44: 521-528, 2003.
30. Newsholme P, Haber EP, Hirabara SM, et al: Diabetes associated cell stress and dysfunction: role of mitochondrial and nonmitochondrial ROS production and activity. J Physiol 583: 9-24, 2007.